tiprankstipranks
Advertisement
Advertisement

RNA Stock Latest News

Leerink starts ‘interesting preclinical-stage opportunity’ Atrium at Outperform
The FlyLeerink starts ‘interesting preclinical-stage opportunity’ Atrium at Outperform
14h ago
RNA
Atrium Therapeutics initiated with an Outperform at Leerink
PremiumThe Fly
Atrium Therapeutics initiated with an Outperform at Leerink
20h ago
RNA
Trump Trade: U.S. plans AI security order without required model tests
PremiumThe Fly
Trump Trade: U.S. plans AI security order without required model tests
4d ago
DYN
RNA
Trump approves plan to fire FDA head Marty Makary, CBS reports
PremiumThe Fly
Trump approves plan to fire FDA head Marty Makary, CBS reports
5d ago
DYN
RNA
Atrium Therapeutics earns $15M development milestone payment from Bristol Myers
PremiumThe Fly
Atrium Therapeutics earns $15M development milestone payment from Bristol Myers
23d ago
BMY
RNA
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
PremiumThe FlyHemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
1M ago
DYN
RNA
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
MUB
NFE
Atrium Therapeutics initiated with an Overweight at Wells Fargo
Premium
The Fly
Atrium Therapeutics initiated with an Overweight at Wells Fargo
2M ago
RNA
Controversial Prasad leaving FDA, NYT reports
PremiumThe Fly
Controversial Prasad leaving FDA, NYT reports
2M ago
AZN
BMY
RNA Earnings this Week: How Will it Perform?
PremiumPre-Earnings
RNA Earnings this Week: How Will it Perform?
3M ago
RNA
Morning News Wrap-Up 2/27/26: Today’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up 2/27/26: Today’s Biggest Stock Market Stories!
3M ago
DIA
RNA
Avidity Biosciences Completes Merger and Plans Nasdaq Delisting
PremiumCompany Announcements
Avidity Biosciences Completes Merger and Plans Nasdaq Delisting
3M ago
8K
RNA
Atrium Therapeutics launches as newly independent, publicly traded company
PremiumThe FlyAtrium Therapeutics launches as newly independent, publicly traded company
3M ago
NVS
RNA
Novartis completes acquisition of Avidity Biosciences
Premium
The Fly
Novartis completes acquisition of Avidity Biosciences
3M ago
NVS
RNA
Why Is Avidity Biosciences Stock (RNA) Down Today?
Premium
Market News
Why Is Avidity Biosciences Stock (RNA) Down Today?
3M ago
NVS
RNA
Avidity Shareholders Approve Novartis Merger and Spin-Off
PremiumCompany Announcements
Avidity Shareholders Approve Novartis Merger and Spin-Off
3M ago
8K
RNA
One new option listing and one option delisting on February 26th
PremiumThe Fly
One new option listing and one option delisting on February 26th
3M ago
RNA
Avidity Biosciences Advances Toward Novartis Merger Completion
PremiumCompany Announcements
Avidity Biosciences Advances Toward Novartis Merger Completion
3M ago
8K
RNA
Avidity Plans Spin-Off Amid Novartis Acquisition Agreement
PremiumCompany Announcements
Avidity Plans Spin-Off Amid Novartis Acquisition Agreement
3M ago
8K
RNA
Avidity Biosciences announces expected record date for spin-off
PremiumThe FlyAvidity Biosciences announces expected record date for spin-off
3M ago
NVS
RNA
Avidity Biosciences Sets February Vote on $72-per-Share Novartis Takeover and Cardiology Spin-Off
Premium
Company Announcements
Avidity Biosciences Sets February Vote on $72-per-Share Novartis Takeover and Cardiology Spin-Off
4M ago
RNA
Avidity Biosciences downgraded to In Line from Outperform at Evercore ISI
Premium
The Fly
Avidity Biosciences downgraded to In Line from Outperform at Evercore ISI
5M ago
RNA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >